Literature DB >> 11279151

Substrate hydrolysis by matrix metalloproteinase-9.

S J Kridel1, E Chen, L P Kotra, E W Howard, S Mobashery, J W Smith.   

Abstract

The catalytic clefts of all matrix metalloproteinases (MMPs) have a similar architecture, raising questions about the redundancy in substrate recognition across the protein family. In the present study, an unbiased phage display strategy was applied to define the substrate recognition profile of MMP-9. Three groups of substrates were identified, each occupying a distinct set of subsites within the catalytic pocket. The most prevalent motif contains the sequence Pro-X-X-Hy-(Ser/Thr) at P(3) through P(2'). This sequence is similar to the MMP cleavage sites within the collagens and is homologous to substrates the have been selected for other MMPs. Despite this similarity, most of the substrates identified here are selective for MMP-9 over MMP-7 and MMP-13. This observation indicates that substrate selectivity is conferred by key subsite interactions at positions other than P(3) and P(1'). This study shows that MMP-9 has a unique preference for Arg at both P(2) and P(1), and a preference for Ser/Thr at P(2'). Substrates containing the consensus MMP-9 recognition motif were used to query the protein data bases. A surprisingly limited list of putative physiologic substrates was identified. The functional implications of these proteins lead to testable hypotheses regarding physiologic substrates for MMP-9.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11279151     DOI: 10.1074/jbc.M100900200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction.

Authors:  Jiqiu Chen; Ching-Hsuan Tung; Jennifer R Allport; Si Chen; Ralph Weissleder; Paul L Huang
Journal:  Circulation       Date:  2005-04-04       Impact factor: 29.690

2.  Altered plasma matrix metalloproteinase-9/tissue inhibitor of matrix [corrected] metalloproteinase-1 concentration during the early postoperative period in patients with colorectal cancer.

Authors:  I Kirman; S Jain; V Cekic; A Belizon; E Balik; P Sylla; T Arnell; K A Forde; R L Whelan
Journal:  Surg Endosc       Date:  2006-01-21       Impact factor: 4.584

Review 3.  Matrix metalloproteinases in the adult brain physiology: a link between c-Fos, AP-1 and remodeling of neuronal connections?

Authors:  Leszek Kaczmarek; Joanna Lapinska-Dzwonek; Sylwia Szymczak
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

4.  Osteopontin is proteolytically processed by matrix metalloproteinase 9.

Authors:  Merry L Lindsey; Fouad A Zouein; Yuan Tian; Rugmani Padmanabhan Iyer; Lisandra E de Castro Brás
Journal:  Can J Physiol Pharmacol       Date:  2015-03-26       Impact factor: 2.273

Review 5.  The history of matrix metalloproteinases: milestones, myths, and misperceptions.

Authors:  Rugmani Padmanabhan Iyer; Nicolle L Patterson; Gregg B Fields; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-17       Impact factor: 4.733

6.  Basis for substrate recognition and distinction by matrix metalloproteinases.

Authors:  Boris I Ratnikov; Piotr Cieplak; Kosi Gramatikoff; James Pierce; Alexey Eroshkin; Yoshinobu Igarashi; Marat Kazanov; Qing Sun; Adam Godzik; Andrei Osterman; Boguslaw Stec; Alex Strongin; Jeffrey W Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-22       Impact factor: 11.205

7.  MMP9-sensitive polymers mediate environmentally-responsive bivalirudin release and thrombin inhibition.

Authors:  D S Chu; D L Sellers; M J Bocek; A E Fischedick; P J Horner; S H Pun
Journal:  Biomater Sci       Date:  2015-01       Impact factor: 6.843

8.  Fluorescence detection of MMP-9. I. MMP-9 selectively cleaves Lys-Gly-Pro-Arg-Ser-Leu-Ser-Gly-Lys peptide.

Authors:  Rafal Fudala; Amalendu P Ranjan; Anindita Mukerjee; Jamboor K Vishwanatha; Zygmunt Gryczynski; Julian Borejdo; Pabak Sarkar; Ignacy Gryczynski
Journal:  Curr Pharm Biotechnol       Date:  2011-05       Impact factor: 2.837

9.  Length-dependent proteolytic cleavage of short oligopeptides catalyzed by matrix metalloprotease-9.

Authors:  Yibing Huang; Junfeng Shi; Dan Yuan; Ning Zhou; Bing Xu
Journal:  Biopolymers       Date:  2013-11       Impact factor: 2.505

Review 10.  MMP induction and inhibition in myocardial infarction.

Authors:  Merry L Lindsey
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.